# Nasal Airway Stent (Nastent®) Study in OSA

> **NCT04305964** · NA · UNKNOWN · sponsor: **University Hospital, Antwerp** · enrollment: 4 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Nastent® (a distally perforated soft silicon nasal tube)
- **DIAGNOSTIC_TEST:** Polygraphy with WatchPAT™ 300

## Key facts

- **NCT ID:** NCT04305964
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04305964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04305964, "Nasal Airway Stent (Nastent®) Study in OSA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04305964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*